应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MNPR Monopar Therapeutics
未开盘 03-13 16:00:00 EDT
60.36
+2.76
+4.79%
盘后
60.36
+0.00
0.00%
17:24 EDT
最高
61.03
最低
58.25
成交量
33.51万
今开
58.57
昨收
57.60
日振幅
4.83%
总市值
4.03亿
流通市值
2.98亿
总股本
668.26万
成交额
1,997万
换手率
6.80%
流通股本
493.15万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Monopar Therapeutics:Leerink Partners开启覆盖,评级为跑赢大盘;目标价115美元
美股速递 · 2025-11-10
Monopar Therapeutics:Leerink Partners开启覆盖,评级为跑赢大盘;目标价115美元
Monopar Therapeutics Inc.宣布1.35亿美元普通股及预付费认股权证承销发行定价
美股速递 · 2025-09-24
Monopar Therapeutics Inc.宣布1.35亿美元普通股及预付费认股权证承销发行定价
Monopar Therapeutics Inc.盘中异动 股价大跌5.27%报30.03美元
市场透视 · 2025-03-06
Monopar Therapeutics Inc.盘中异动 股价大跌5.27%报30.03美元
Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.10%
市场透视 · 2025-03-03
Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.10%
Monopar Therapeutics Inc.盘中异动 早盘急速拉升7.04%报32.38美元
市场透视 · 2025-02-28
Monopar Therapeutics Inc.盘中异动 早盘急速拉升7.04%报32.38美元
Monopar Therapeutics Inc.盘中异动 大幅上涨5.24%报32.74美元
市场透视 · 2025-02-26
Monopar Therapeutics Inc.盘中异动 大幅上涨5.24%报32.74美元
Monopar Therapeutics Inc.盘中异动 急速跳水5.39%
市场透视 · 2025-02-24
Monopar Therapeutics Inc.盘中异动 急速跳水5.39%
Monopar Therapeutics Inc.盘中异动 股价大跌7.62%报40.76美元
市场透视 · 2025-02-19
Monopar Therapeutics Inc.盘中异动 股价大跌7.62%报40.76美元
Monopar Therapeutics Inc.盘中异动 早盘急速下挫5.21%
市场透视 · 2025-02-13
Monopar Therapeutics Inc.盘中异动 早盘急速下挫5.21%
Monopar Therapeutics Inc.盘中异动 急速跳水5.00%
市场透视 · 2025-02-12
Monopar Therapeutics Inc.盘中异动 急速跳水5.00%
Monopar Therapeutics Inc.盘中异动 股价大跌11.24%
市场透视 · 2025-02-03
Monopar Therapeutics Inc.盘中异动 股价大跌11.24%
Monopar Therapeutics Inc.盘中异动 早盘股价大涨5.64%报40.99美元
市场透视 · 2025-01-30
Monopar Therapeutics Inc.盘中异动 早盘股价大涨5.64%报40.99美元
Monopar Therapeutics Inc.盘中异动 股价大跌5.91%报39.01美元
市场透视 · 2025-01-27
Monopar Therapeutics Inc.盘中异动 股价大跌5.91%报39.01美元
Monopar Therapeutics Inc.盘中异动 早盘大幅上涨5.57%
市场透视 · 2025-01-24
Monopar Therapeutics Inc.盘中异动 早盘大幅上涨5.57%
Monopar Therapeutics Inc.盘中异动 临近午盘股价大涨5.26%报35.44美元
市场透视 · 2025-01-24
Monopar Therapeutics Inc.盘中异动 临近午盘股价大涨5.26%报35.44美元
Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.55%
市场透视 · 2025-01-22
Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.55%
Monopar Therapeutics Inc.股价重挫10.20% 市值跌709.13万美元
市场透视 · 2025-01-17
Monopar Therapeutics Inc.股价重挫10.20% 市值跌709.13万美元
Monopar Therapeutics Inc.盘中异动 急速跳水5.15%
市场透视 · 2025-01-08
Monopar Therapeutics Inc.盘中异动 急速跳水5.15%
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.03%
市场透视 · 2024-12-31
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.03%
Monopar Therapeutics Inc.盘中异动 股价大跌5.50%报23.18美元
市场透视 · 2024-12-31
Monopar Therapeutics Inc.盘中异动 股价大跌5.50%报23.18美元
加载更多
公司概况
公司名称:
Monopar Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Monopar Therapeutics Inc.最初于2014年12月5日在特拉华州注册成立,是一家有限责任公司,并于2015年12月16日通过免税交易所转换为C公司,当时该公司进行了1对10的反向股票分割。该公司是一家临床阶段的生物制药公司,专注于为癌症患者开发创新治疗方法。
发行价格:
--
{"stockData":{"symbol":"MNPR","market":"US","secType":"STK","nameCN":"Monopar Therapeutics","latestPrice":60.36,"timestamp":1773432000000,"preClose":57.6,"halted":0,"volume":335125,"hourTrading":{"tag":"盘后","latestPrice":60.36,"preClose":60.36,"latestTime":"17:24 EDT","volume":683,"amount":41227.99,"timestamp":1773437045044,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04791666666666663,"floatShares":4931541,"shares":6682584,"eps":-2.989461,"marketStatus":"未开盘","change":2.76,"latestTime":"03-13 16:00:00 EDT","open":58.57,"high":61.03,"low":58.25,"amount":19969157.04875,"amplitude":0.048264,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.989461,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":0,"adr":0,"listingDate":1576731600000,"exchange":"NASDAQ","adjPreClose":57.6,"postHourTrading":{"tag":"盘后","latestPrice":60.36,"preClose":60.36,"latestTime":"17:24 EDT","volume":683,"amount":41227.99,"timestamp":1773437045044,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.3279253822739805},"requestUrl":"/m/hq/s/MNPR","defaultTab":"news","newsList":[{"id":"1186385711","title":"Monopar Therapeutics:Leerink Partners开启覆盖,评级为跑赢大盘;目标价115美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186385711","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186385711?lang=zh_cn&edition=full","pubTime":"2025-11-10 19:08","pubTimestamp":1762772889,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics:Leerink Partners开启覆盖,评级为跑赢大盘;目标价115美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNPR","BK4139"],"gpt_icon":0},{"id":"1106697600","title":"Monopar Therapeutics Inc.宣布1.35亿美元普通股及预付费认股权证承销发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1106697600","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106697600?lang=zh_cn&edition=full","pubTime":"2025-09-24 11:09","pubTimestamp":1758683354,"startTime":"0","endTime":"0","summary":"Monopar Therapeutics Inc.宣布1.35亿美元普通股及预付费认股权证承销发行定价","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MNPR"],"gpt_icon":0},{"id":"2517947175","title":"Monopar Therapeutics Inc.盘中异动 股价大跌5.27%报30.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517947175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517947175?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:33","pubTimestamp":1741195992,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时33分,Monopar Therapeutics Inc.股票出现异动,股价大幅下跌5.27%。截至发稿,该股报30.03美元/股,成交量6589股,换手率0.11%,振幅6.21%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.29%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013312989d6e8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013312989d6e8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2516634207","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634207?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:38","pubTimestamp":1741012721,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时38分,Monopar Therapeutics Inc.股票出现波动,股价快速上涨6.10%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Entero Therapeutics Inc.、Geovax Labs, Inc.、Alto Neuroscience, Inc.涨幅较大,Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为48.70%、43.08%、31.69%,振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Vincerx Pharma, Inc.,振幅分别为27.57%、19.25%、18.04%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238419637ae43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032238419637ae43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2514376347","title":"Monopar Therapeutics Inc.盘中异动 早盘急速拉升7.04%报32.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376347?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:29","pubTimestamp":1740756552,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时29分,Monopar Therapeutics Inc.股票出现波动,股价快速拉升7.04%。截至发稿,该股报32.38美元/股,成交量1.8378万股,换手率0.30%,振幅3.87%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232912963426fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232912963426fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","BK4139","LENZ"],"gpt_icon":0},{"id":"2514852276","title":"Monopar Therapeutics Inc.盘中异动 大幅上涨5.24%报32.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514852276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514852276?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:48","pubTimestamp":1740584889,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时48分,Monopar Therapeutics Inc.股票出现波动,股价急速上涨5.24%。截至发稿,该股报32.74美元/股,成交量1.1134万股,换手率0.18%,振幅7.27%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.02%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623480996315e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022623480996315e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2513072065","title":"Monopar Therapeutics Inc.盘中异动 急速跳水5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513072065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513072065?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409550,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分,Monopar Therapeutics Inc.股票出现异动,股价大幅下跌5.39%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大,Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为163.29%、71.43%、25.67%,振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ,振幅分别为137.23%、55.69%、42.86%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230550a2521cfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230550a2521cfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MNPR","BK4139"],"gpt_icon":0},{"id":"2512485959","title":"Monopar Therapeutics Inc.盘中异动 股价大跌7.62%报40.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512485959?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:59","pubTimestamp":1739977146,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时59分,Monopar Therapeutics Inc.股票出现异动,股价急速跳水7.62%。截至发稿,该股报40.76美元/股,成交量2170股,换手率0.04%,振幅0.84%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.47%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225906a24c015c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219225906a24c015c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"gpt_icon":0},{"id":"2511627529","title":"Monopar Therapeutics Inc.盘中异动 早盘急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511627529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511627529?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:06","pubTimestamp":1739459179,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时06分,Monopar Therapeutics Inc.股票出现异动,股价快速下挫5.21%。截至发稿,该股报47.89美元/股,成交量5553股,换手率0.09%,振幅2.53%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.18%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230619abcdb8bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230619abcdb8bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"gpt_icon":0},{"id":"2510330545","title":"Monopar Therapeutics Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510330545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510330545?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:22","pubTimestamp":1739294530,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时22分,Monopar Therapeutics Inc.股票出现波动,股价快速下挫5.00%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.90%。其相关个股中,Omega Therapeutics, Inc.、Oramed Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为3037.33%、1356.66%、447.02%,振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为143.33%、59.46%、58.60%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120122109881d9f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120122109881d9f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MNPR","BK4139"],"gpt_icon":0},{"id":"2508149424","title":"Monopar Therapeutics Inc.盘中异动 股价大跌11.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149424?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分,Monopar Therapeutics Inc.股票出现波动,股价急速下挫11.24%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.36%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为351.55%、306.17%、140.67%,振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.,振幅分别为57.23%、33.33%、26.50%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223525a2380a96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223525a2380a96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2507162441","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大涨5.64%报40.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507162441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507162441?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:50","pubTimestamp":1738248605,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时50分,Monopar Therapeutics Inc.股票出现波动,股价快速上涨5.64%。截至发稿,该股报40.99美元/股,成交量5744股,换手率0.09%,振幅2.96%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225006abbd5020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225006abbd5020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNPR","BK4139","LENZ"],"gpt_icon":0},{"id":"2506303573","title":"Monopar Therapeutics Inc.盘中异动 股价大跌5.91%报39.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506303573?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988352,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分,Monopar Therapeutics Inc.股票出现异动,股价大幅下挫5.91%。截至发稿,该股报39.01美元/股,成交量4428股,换手率0.07%,振幅1.09%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223232a2316aff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223232a2316aff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2506867971","title":"Monopar Therapeutics Inc.盘中异动 早盘大幅上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506867971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506867971?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:45","pubTimestamp":1737733550,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时45分,Monopar Therapeutics Inc.股票出现波动,股价快速上涨5.57%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.涨幅较大,Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为3660.40%、1893.42%、1403.54%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.,振幅分别为134.08%、112.09%、66.25%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242345509872114f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242345509872114f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0},{"id":"2505045913","title":"Monopar Therapeutics Inc.盘中异动 临近午盘股价大涨5.26%报35.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505045913?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:32","pubTimestamp":1737649953,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时32分,Monopar Therapeutics Inc.股票出现波动,股价大幅上涨5.26%。截至发稿,该股报35.44美元/股,成交量2.062万股,换手率0.34%,振幅4.25%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.47%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003234a22d2318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124003234a22d2318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MNPR","BK4139"],"gpt_icon":0},{"id":"2505120580","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大涨6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505120580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505120580?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:18","pubTimestamp":1737476310,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时18分,Monopar Therapeutics Inc.股票出现波动,股价急速上涨6.55%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.63%。其相关个股中,Channel Therapeutics Corporation、Genelux Corporation、Dogwood Therapeutics, Inc.涨幅较大,Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为757.01%、474.40%、182.29%,振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.,振幅分别为96.32%、41.33%、38.48%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001830960bcd6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001830960bcd6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","MNPR"],"gpt_icon":0},{"id":"2504164055","title":"Monopar Therapeutics Inc.股价重挫10.20% 市值跌709.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504164055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504164055?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:39","pubTimestamp":1737124765,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时39分,Monopar Therapeutics Inc.股票出现异动,股价快速下跌10.20%。截至发稿,该股报27.37美元/股,成交量4844股,换手率0.08%,振幅8.80%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.33%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223925986a1708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223925986a1708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"gpt_icon":0},{"id":"2501773532","title":"Monopar Therapeutics Inc.盘中异动 急速跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501773532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501773532?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:31","pubTimestamp":1736346684,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时31分,Monopar Therapeutics Inc.股票出现波动,股价急速下跌5.15%。截至发稿,该股报23.87美元/股,成交量580股,换手率0.01%,振幅0.00%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223125aba34a9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223125aba34a9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"gpt_icon":0},{"id":"2495161937","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495161937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495161937?lang=zh_cn&edition=full","pubTime":"2024-12-31 23:11","pubTimestamp":1735657918,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日23时11分,Monopar Therapeutics Inc.股票出现波动,股价急速下挫5.03%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,知临集团、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Eyenovia, Inc.涨幅较大,知临集团、Eyenovia, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1028.37%、216.96%、62.67%,振幅较大的相关个股有知临集团、Eyenovia, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为119.56%、65.84%、65.50%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231231158a210938c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231231158a210938c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNPR","LENZ"],"gpt_icon":0},{"id":"2495577855","title":"Monopar Therapeutics Inc.盘中异动 股价大跌5.50%报23.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495577855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495577855?lang=zh_cn&edition=full","pubTime":"2024-12-31 03:33","pubTimestamp":1735587215,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日03时33分,Monopar Therapeutics Inc.股票出现异动,股价急速跳水5.50%。截至发稿,该股报23.18美元/股,成交量3.9636万股,换手率0.65%,振幅6.40%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.19%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123103333595f2fe03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123103333595f2fe03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MNPR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.monopartx.com","stockEarnings":[{"period":"1week","weight":0.0477},{"period":"1month","weight":0.0163},{"period":"3month","weight":-0.1909},{"period":"6month","weight":0.2263},{"period":"1year","weight":1.0468},{"period":"ytd","weight":-0.0757}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Monopar Therapeutics Inc.最初于2014年12月5日在特拉华州注册成立,是一家有限责任公司,并于2015年12月16日通过免税交易所转换为C公司,当时该公司进行了1对10的反向股票分割。该公司是一家临床阶段的生物制药公司,专注于为癌症患者开发创新治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.22612},{"month":2,"riseRate":0.285714,"avgChangeRate":0.090755},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.168014},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.030342},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.085228},{"month":6,"riseRate":0.666667,"avgChangeRate":0.04528},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.047687},{"month":8,"riseRate":0,"avgChangeRate":-0.159034},{"month":9,"riseRate":0.333333,"avgChangeRate":0.484161},{"month":10,"riseRate":0.5,"avgChangeRate":0.223985},{"month":11,"riseRate":0.666667,"avgChangeRate":0.047001},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.031256}],"exchange":"NASDAQ","name":"Monopar Therapeutics","nameEN":"Monopar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Monopar Therapeutics,MNPR,Monopar Therapeutics股票,Monopar Therapeutics股票老虎,Monopar Therapeutics股票老虎国际,Monopar Therapeutics行情,Monopar Therapeutics股票行情,Monopar Therapeutics股价,Monopar Therapeutics股市,Monopar Therapeutics股票价格,Monopar Therapeutics股票交易,Monopar Therapeutics股票购买,Monopar Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}